Both control and empagliflozin-treated adult SHR-CRP rats exhibited moderate changes with focal segmental glomerular sclerosis accompanied by smaller areas of tubular atrophy when compared to empagliflozin-treated rats. Here, CRP is linked to glomerulosclerosis.